SEC Form D filing

iBio, Inc., 2026-01-22

An SEC Form D private-offering notice from San Diego, CA, a $25,985,431 filer-stated offering target in Biotech. Filed 2026-01-22. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

iBio, Inc. site↗ Verified via SEC Form D

AI driven biotechnology company developing precision antibodies to treat obesity and cardiometabolic disease.

Filed 2026-01-22Filed to raise $25,985,431First money in 2026-01-08Raised so far $25,985,431HQ (as filed) San Diego, CASector Biotech web-verified against the company’s own siteStage (inferred) Growth
Source linked the Form D on EDGAR↗Website verified ibioinc.com↗Named in the filing 9 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source